Zydus Lifesciences is launching its largest share buyback program to date. The company plans to repurchase shares worth Rs 1,100 crore. This move offers shareholders a premium price. The record date for eligibility is May 29. The buyback will be conducted through a tender route. This follows previous successful buyback initiatives by the company.
Tamilnad Mercantile Bank Q1 profit jumps 35% on strong income growth
Tamilnad Mercantile Bank reported a 35% year-on-year rise in June quarter net profit to Rs 412 crore, driven by higher income and net interest income.